1.75
+0.06(+3.55%)
Currency In USD
| Previous Close | 1.69 |
| Open | 1.72 |
| Day High | 1.84 |
| Day Low | 1.63 |
| 52-Week High | 18 |
| 52-Week Low | 1.09 |
| Volume | 108,061 |
| Average Volume | 3.52M |
| Market Cap | 13.41M |
| PE | -0.1 |
| EPS | -17.76 |
| Moving Average 50 Days | 1.32 |
| Moving Average 200 Days | 2.64 |
| Change | 0.06 |
If you invested $1000 in Eterna Therapeutics Inc. (ERNA) 10 years ago, it would be worth $0.23 as of November 08, 2025 at a share price of $1.75. Whereas If you bought $1000 worth of Eterna Therapeutics Inc. (ERNA) shares 5 years ago, it would be worth $1.54 as of November 08, 2025 at a share price of $1.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform
GlobeNewswire Inc.
Nov 06, 2025 2:15 PM GMT
Access the “What This Means” segment here CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, tod
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa
GlobeNewswire Inc.
Oct 01, 2025 12:30 PM GMT
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced its upcoming company presentation at the Cell
Ernexa Therapeutics President & CEO Sanjeev Luther to Present on Expert Panel at 5th Annual iPSC Drug Development Summit
GlobeNewswire Inc.
Sep 29, 2025 12:30 PM GMT
CAMBRIDGE, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that its President and CEO, Sanjeev Luther, w